ArticleInternational journal of surgery. Oncology2017

Metastatic melanoma patients' sensitivity to ipilimumab cannot be predicted by tumor characteristics.

Kara Rossfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.